Metformin Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

100 Suppliers, 55 USDMF, 40 CEP/COS, 13 JDMF, 29 EU WC, 96 KDMF, 37 NDC API, 38 Listed Suppliers

DEVELOPMENTS

22 Drug(s) in Development

22 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

1623 Dossiers, 411 FDA Orange Book, 375 Europe, 117 Canada, 119 Australia, 132 South Africa, 469 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE, TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE, TABLET;ORAL - 2.5MG;1GM, TABLET;ORAL - 2.5MG;500MG, TABLET;ORAL - 2.5MG;850MG, TABLET;ORAL - EQ 12.5MG BASE;1GM, TABLET;ORAL - EQ 12.5MG BASE;500MG, TABLET;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM, TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG, TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM, TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG, TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION, EXTENDED RELEASE;ORAL - 500MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 1GM, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 500MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 1GM, TABLET, EXTENDED RELEASE;ORAL - 500MG, TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 850MG;EQ 15MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE, TABLET;ORAL - 1GM;EQ 50MG BASE, TABLET;ORAL - 500MG;EQ 50MG BASE, TABLET;ORAL - 500MG;1MG, TABLET;ORAL - 500MG;2MG

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 38 BASF, 35 Roquette, 27 Corel Pharma Chem, 22 Microlex e.U, 22 SPI Pharma, 15 DKSH, 14 Gangwal Healthcare, 14 Seppic, 13 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Chemicals, 12 Nanjing Well Pharmaceutical, 12 Actylis, 12 Sigachi Industries, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Rochem International Inc, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 DFE Pharma, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 Prachin Chemical, 5 Kima Chemical, 5 Lubrizol Life Science Health, 5 Ingredion Pharma Solutions, 5 Pharmatrans-Sanaq, 4 The Dow Chemical Company, 4 Ulanqab Kema New Material, 4 Evonik, 4 Vasa Pharmachem, 4 Alcedo Pharmachem, 3 Aeon Procare, 3 Pharm-RX Chemical, 3 Valens Pharmachem, 3 Jai Radhe Sales, 2 Zhejiang Huakang Pharmaceutical, 2 Clariant, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Minakem, 2 Seqens, 2 Finar, 2 Pfanstiehl, 2 Vertellus, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Avesta Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Bioplus Life Sciences, 1 Doshion Polyscience, 1 NEWEDGE Overseas, 1 Huzhou Sunflower Pharmaceutical, 1 Chynops Pharma, 1 ACG Worldwide

EXCIPIENTS BY APPLICATIONS

120 Fillers, Diluents & Binders, 64 Coating Systems & Additives, 58 Direct Compression, 58 Controlled & Modified Release, 50 Disintegrants & Superdisintegrants, 47 Solubilizers, 47 Thickeners and Stabilizers, 40 Granulation, 37 Taste Masking, 37 Film Formers & Plasticizers, 34 Topical, 31 Lubricants & Glidants, 30 Parenteral, 24 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 14 Emulsifying Agents, 12 API Stability Enhancers, 10 Rheology Modifiers, 5 Coloring Agents, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 335 Finished Drug Prices

MARKET PLACE

75 APIs, 51 DOSSIERS // FDF

PATENTS

538 US Patents, 40 US Exclusivities, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 BioAnalytical Methods, 1 Analytical Solutions, 3 EDQM, 3 USP, 11 Others

DIGITAL CONTENT

20 Data Compilation & Company Tracker #PharmaFlow, 351 News

Filters

FILTER :

filter Product

All (3)

01 Equa/EquMet (1)

02 Janumet (1)

03 Trajenta/Jentadueto (1)

Boehringer Ingelheim

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Germany

Virtual Booth

Digital Content

Metformin Hydrochloride

PDF Supplier PDF

URL Supplier Web Content

Product Name

Trajenta/ Jentadueto

Main Therapeutic Indication

Diabetes

Currency

EURO

2020 Revenue in Millions

1,512

2019 Revenue in Millions

1,559

2020 Revenue in Millions (USD)

1,801

2019 Revenue in Millions (USD)

1,857

Sales Difference in Millions (USD)

-56

Growth (%)

-3

ASK
US

Upload
your Marketing & Sales content

Dainippon Sumitomo

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Metformin

PDF Supplier PDF

URL Supplier Web Content

Product Name

Equa/EquMet

Main Therapeutic Indication

Diabetes

Currency

YEN

2020 Revenue in Millions

41

2019 Revenue in Millions

8

2020 Revenue in Millions (USD)

391

2019 Revenue in Millions (USD)

75

Sales Difference in Millions (USD)

316

Growth (%)

421

ASK
US

Upload
your Marketing & Sales content

Johnson & Johnson

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Metformin HCl

PDF Supplier PDF

URL Supplier Web Content

Product Name

Invokana/Invokamet

Main Therapeutic Indication

Diabetes

Currency

USD

2020 Revenue in Millions

795

2019 Revenue in Millions

735

2020 Revenue in Millions (USD)

795

2019 Revenue in Millions (USD)

735

Sales Difference in Millions (USD)

60

Growth (%)

8

ASK
US

Upload
your Marketing & Sales content

Merck

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Metformin

PDF Supplier PDF

URL Supplier Web Content

Product Name

Janumet

Main Therapeutic Indication

Diabetes

Currency

USD

2020 Revenue in Millions

1,971

2019 Revenue in Millions

2,041

2020 Revenue in Millions (USD)

1,971

2019 Revenue in Millions (USD)

2,041

Sales Difference in Millions (USD)

-70

Growth (%)

-3

ASK
US

Upload
your Marketing & Sales content

Boehringer Ingelheim

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Germany

Virtual Booth

Digital Content

Metformin Hydrochloride

PDF Supplier PDF

URL Supplier Web Content

Product Name

Trajenta/ Jentadueto

Main Therapeutic Indication

Diabetes

Currency

EURO

2021 Revenue in Millions

1,552

2020 Revenue in Millions

1,512

2021 Revenue in Millions (USD)

1,709

2020 Revenue in Millions (USD)

1,801

Sales Difference in Millions (USD)

-92

Growth (%)

3

ASK
US

Upload
your Marketing & Sales content

Dainippon Sumitomo

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Metformin

PDF Supplier PDF

URL Supplier Web Content

Product Name

Equa/EquMet

Main Therapeutic Indication

Diabetes

Currency

YEN

2021 Revenue in Millions

38

2020 Revenue in Millions

41

2021 Revenue in Millions (USD)

322

2020 Revenue in Millions (USD)

391

Sales Difference in Millions (USD)

-69

Growth (%)

-6

ASK
US

Upload
your Marketing & Sales content

Johnson & Johnson

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Metformin HCl

PDF Supplier PDF

URL Supplier Web Content

Product Name

Invokana/Invokamet

Main Therapeutic Indication

Diabetes

Currency

USD

2021 Revenue in Millions

563

2020 Revenue in Millions

795

2021 Revenue in Millions (USD)

563

2020 Revenue in Millions (USD)

795

Sales Difference in Millions (USD)

-232

Growth (%)

-29

ASK
US

Upload
your Marketing & Sales content

Merck

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Metformin

PDF Supplier PDF

URL Supplier Web Content

Product Name

Janumet

Main Therapeutic Indication

Diabetes

Currency

USD

2021 Revenue in Millions

1,964

2020 Revenue in Millions

1,971

2021 Revenue in Millions (USD)

1,964

2020 Revenue in Millions (USD)

1,971

Sales Difference in Millions (USD)

-7

Growth (%)

0

ASK
US

Upload
your Marketing & Sales content

Boehringer Ingelheim

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Germany

Virtual Booth

Digital Content

Metformin Hydrochloride

PDF Supplier PDF

URL Supplier Web Content

Product Name

Trajenta/Jentadueto

Main Therapeutic Indication

Diabetes

Currency

EURO

2022 Revenue in Millions

1,703

2021 Revenue in Millions

1,552

2022 Revenue in Millions (USD)

1,846

2021 Revenue in Millions (USD)

1,709

Sales Difference in Millions (USD)

137

Growth (%)

8

ASK
US

Upload
your Marketing & Sales content

Merck & Co.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Metformin

PDF Supplier PDF

URL Supplier Web Content

Product Name

Janumet

Main Therapeutic Indication

Diabetes

Currency

USD

2022 Revenue in Millions

1,700

2021 Revenue in Millions

1,964

2022 Revenue in Millions (USD)

1,700

2021 Revenue in Millions (USD)

1,964

Sales Difference in Millions (USD)

-264

Growth (%)

-13

ASK
US

Upload
your Marketing & Sales content

Annual Sales of Metformin Hydrochloride reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Metformin Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

100 Suppliers

55 USDMF

40 CEP/COS

13 JDMF

29 EU WC

96 KDMF

37 NDC API

38 Listed Suppliers

DEVELOPMENTS

22 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

1623 Dossiers

411 FDA Orange Book

375 Europe

117 Canada

119 Australia

132 South Africa

469 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE

TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE

TABLET;ORAL - 2.5MG;1GM

TABLET;ORAL - 2.5MG;500MG

TABLET;ORAL - 2.5MG;850MG

TABLET;ORAL - EQ 12.5MG BASE;1GM

TABLET;ORAL - EQ 12.5MG BASE;500MG

TABLET;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM

TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG

TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM

TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG

TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SUSPENSION, EXTENDED RELEASE;ORAL - 500MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 1GM

TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 500MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 1GM

TABLET, EXTENDED RELEASE;ORAL - 500MG

TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 850MG;EQ 15MG BASE

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE

TABLET;ORAL - 1GM;EQ 50MG BASE

TABLET;ORAL - 500MG;EQ 50MG BASE

TABLET;ORAL - 500MG;1MG

TABLET;ORAL - 500MG;2MG

RELATED EXCIPIENT COMPANIES

Suppliers

39 Kerry

38 BASF

35 Roquette

27 Corel Pharma Chem

22 Microlex e.U

22 SPI Pharma

15 DKSH

14 Gangwal Healthcare

14 Seppic

13 Boai NKY Pharmaceuticals Ltd

13 Gangwal Chemicals

12 Nanjing Well Pharmaceutical

TABLET;ORAL - 1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 625MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 750MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 850MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 1.25MG;250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 2.5MG;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 750MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 500MG;EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons